Dr Mark McClure

Consultant Nephrologist

No Referral Needed

You can access my services directly, no GP referral required.

Book an Appointment

Accepted Insurers

Allianz
AXA
Bupa
H3
Vhi
Vitality
WPA

Our Locations

We see patients across the Kingsbridge sites, all with high standards of care.

You’ll receive the same consistent, personalised support throughout.

Belfast

Services I Offer

Nephrology

Dr Mark McClure’s Profile

Dr Mark McClure is a kidney specialist (Consultant Nephrologist) at Belfast Health and Social Care Trust, caring for people with a wide range of kidney problems. He looks after conditions such as chronic kidney disease, high blood pressure, kidney stones (prevention and medical management), electrolyte imbalances and inflammatory diseases that affect the kidney’s filters, including vasculitis and lupus.

He qualified in 2008 and went on to complete advanced kidney and transplant training in specialist centres in Cambridge and Bristol before joining the Belfast kidney team in 2024. He holds a PhD from the University of Cambridge, where he researched new treatments targeting the immune system in certain types of vasculitis, and is an Honorary Lecturer at Queen’s University Belfast, with active involvement in clinical research.

Patients describe Dr McClure as approachable and attentive, explaining options in clear language, and involving patients and their families in every step of their care.

Current NHS/HSE Posts

Consultant Nephrologist at Belfast HSC Trust

Treatments areas of interest

Chronic kidney disease
High blood pressure
Kidney stones (prevention and medical management)
Electrolyte imbalances
Inflammatory diseases that affect the kidney’s filters, including vasculitis and lupus

Qualifications

MBBS, University of Wales, College of Medicine, Cardiff, 2008
MRCP 2012
MRCP Specialty Certificate Examination in Nephrology / ESENeph, 2022
GMC Full Registration No. 7015020
PhD in Medicine, University of Cambridge, 2022
CCT in Renal and General Internal Medicine, East of England Deanery, 2023

Professional bodies (Positions held in last 3 years)

GMC Full Registration No. 7015020
MDU Registration No. 460928D

Publications

A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol. McClure, M.E, Gopaluni, S, Wason, J. et al. Trials. 2023.
Age and time-dependent increase in incident anti-glomerular basement membrane (anti-GBM) disease: a nation-wide cohort study. Karl Emil Nelveg-Kristensen, Bo Madsen, Mark McClure, et al. CKJ. 2023
Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction Models. Mark E McClure, Yajing Zhu, Rona M Smith, et al. Rheumatology. 2021
Treatment of Relapses in ANCA-Associated Vasculitis. McClure M, Jones RB. Clinical Journal of American Society of Nephrology. 2019.
Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis. McClure ME, Wason J, Gopaluni S, et al. Journal of Clinical Rheumatology. 2019
B cell therapy in ANCA-associated vasculitis: current and emerging treatment options. McClure M, Gopaluni S, Jayne D, Jones R. Nature Reviews Rheumatology. 2018
Long-term graft outcomes and patient survival are lower post-transplant in patients with a primary renal diagnosis of glomerulonephritis. Rishi Pruthi, Mark McClure, Anna Casula, et al. Kidney International 2016

Book An Appointment

Book an appointment online or get in touch with us directly.